Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer
ConclusionsLong-term adjuvant AI treatment negatively influenced bone quality in addition to BMD in patients with breast cancer. This study suggests that early monitoring and management are needed in non-osteoporotic patients with breast cancer who are starting AIs.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | DEXA Scan | Orthopaedics | Osteoporosis | Study | Women